Walmart: Ozempic And Its Potential Impact On Grocery Sales

Summary:

  • Walmart recently attracted attention when an executive pointed out shopping trends in customers using weight loss drugs such as Ozempic.
  • Anonymized data on shoppers using these drugs showed evidence of a pullback in their overall baskets.
  • As an increasing number of people turn to these medication-based treatments for weight loss, there is a risk of lost sales to grocery-exposed retailers.
  • While the risk to WMT is worth consideration, I don’t view it as a significant hurdle for investment.

Walmart Raises Its Minimum Wage To 14 Dollars An Hour

Joe Raedle

Walmart (NYSE:WMT) attracted attention last week when CEO of U.S. Operations, John Furner, said in an interview that increased usage of drugs taken for weight loss is beginning to have an impact on shopping behavior; specifically, that those using the products are


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *